I decided not to take the drugs
Dramatically increasing fiber intake all at once overwhelms a digestive system that is already struggling with slowed motility
Dose escalation strategies were identified as crucial for managing these adverse events and improving patient adherence
Interaction of smoking and metabolic syndrome on cardiovascular risk in a Chinese cohort
Cardiovascular Outcomes This section reviews current evidence regarding GLP-1 RAs effects on MACE, PAD, CAD, HF, blood pressure, and AF, with detailed findings of trials and meta-analyses discussed in Tables 1 and 2 Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD
International Journal of Molecular Sciences, 25 (2), 1087